{"filing":{"accession_number":"0001654954-26-006637","cik":"0000901832","ticker":"AZN","company_name":"ASTRAZENECA PLC","form":"6-K","filing_date":"2026-07-14","report_date":null,"primary_document":"a2449m.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/901832/000165495426006637/a2449m.htm"},"events":[{"id":17722,"run_id":15888,"accession_number":"0001654954-26-006637","anchor_item_number":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"AstraZeneca has entered into an exclusive global license agreement with Dizal Pharmaceutical to acquire worldwide rights to develop and commercialize Zegfrovy (sunvozertinib), a novel EGFR inhibitor for lung cancer. The transaction involves an upfront payment of $600 million plus up to $900 million in milestone payments, representing a material acquisition of intellectual property and commercial rights that would affect a reasonable investor's assessment of the company's oncology portfolio and capital allocation.","company_name":"ASTRAZENECA PLC","ticker":"AZN","filing_date":"2026-07-14","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":16298,"accession_number":"0001654954-26-006637","item_number":null,"item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"AstraZeneca has entered into an exclusive global license agreement with Dizal Pharmaceutical to acquire worldwide rights to develop and commercialize Zegfrovy (sunvozertinib), a novel EGFR inhibitor for lung cancer. The transaction involves an upfront payment of $600 million plus up to $900 million in milestone payments, representing a material acquisition of intellectual property and commercial rights that would affect a reasonable investor's assessment of the company's oncology portfolio and capital allocation.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-14T10:38:36.958266+00:00","company_name":"ASTRAZENECA PLC","ticker":"AZN","filing_date":"2026-07-14"}]}